Shugan Xiaozhi Formula Reduces Hepatic Steatosis and Stiffness in MASLD Patients with Elevated ALT: An Exploratory 24-Week Randomized Trial.
SGXZ was associated with greater reductions in hepatic steatosis, imaging-based liver stiffness, body weight, BMI, and WHR than vitamin E, with an acceptable safety profile, and these findings suggest that SGXZ represents a highly promising compound natural medicine therapeutic option for the complex metabolic diseases...